0001179110-21-008903.txt : 20210923 0001179110-21-008903.hdr.sgml : 20210923 20210923163540 ACCESSION NUMBER: 0001179110-21-008903 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210922 FILED AS OF DATE: 20210923 DATE AS OF CHANGE: 20210923 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Thackray Helen M. CENTRAL INDEX KEY: 0001589725 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17999 FILM NUMBER: 211272921 MAIL ADDRESS: STREET 1: C/O GLYCOMIMETICS, INC. STREET 2: 401 PROFESSIONAL DRIVE, SUITE 250 CITY: GAITHERSBURG STATE: MD ZIP: 20879 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ImmunoGen, Inc. CENTRAL INDEX KEY: 0000855654 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042726691 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 830 WINTER ST CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (781)895-0600 MAIL ADDRESS: STREET 1: 830 WINTER ST CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOGEN INC DATE OF NAME CHANGE: 19920703 4 1 edgar.xml FORM 4 - X0306 4 2021-09-22 0 0000855654 ImmunoGen, Inc. IMGN 0001589725 Thackray Helen M. C/O IMMUNOGEN, INC. 830 WINTER STREET WALTHAM MA 02451 1 0 0 0 Deferred Share Unit 0 2021-09-22 4 A 0 30000 0 A Common Stock 30000 30000 D Stock Option (right to buy) 5.97 2021-09-22 4 A 0 44000 5.97 A 2031-09-22 Common Stock 44000 44000 D The deferred share units were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors and are convertible into Common Stock on a one-to-one basis. The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors. The deferred share units vest ratably over a three-year period in quarterly increments beginning on December 1, 2021, contingent upon the individual remaining a director as of each vesting date. The stock options vest ratably over a three-year period in quarterly increments beginning on December 1, 2021, contingent upon the individual remaining a director as of each vesting date. /s/ Renee Lentini, attorney in fact 2021-09-23